Ovarian Suppression Treatment Is Rare for Premenopausal Women with HR+/HER2+ Breast Cancer
In serious-environment follow, use of ovarian suppression treatment was not common amongst premenopausal individuals with
Ovarian
Black women less likely to receive guideline-concordant therapy for ovarian cancer
November 09, 2022 3 min read Source/Disclosures Published by: Disclosures: The NCI supported this study.
Study could help recommend the best treatment for women with early-stage mucinous ovarian cancer
A world wide research into mucinous ovarian cancer could enable oncologists advise the best therapy